Astellas Pharma (STU:YPH) Pre-Tax Income : €-494 Mil (TTM As of Dec. 2024)

Astellas Pharma Pre-Tax Income Chart

Astellas Pharma Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
Pre-Tax Income		Get a 7-Day Free Trial					2,062.30	1,123.03	1,201.35	924.89	153.33

Astellas Pharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Pre-Tax Income	Get a 7-Day Free Trial															110.26	-298.82	297.16	242.95	-734.87

Competitive Comparison of Astellas Pharma's Pre-Tax Income

For the Drug Manufacturers - General subindustry, Astellas Pharma's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Astellas Pharma's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Astellas Pharma's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Astellas Pharma's Pre-Tax Income falls into.

Astellas Pharma Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Astellas Pharma's Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as

Astellas Pharma's Pretax Income for the quarter that ended in Dec. 2024 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-494 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astellas Pharma  (STU:YPH) Pre-Tax Income Explanation

Astellas Pharma's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

During the past 13 years, Astellas Pharma's highest Pretax Margin was 21.48%. The lowest was -4.18%. And the median was 15.99%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astellas Pharma Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Astellas Pharma's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Astellas Pharma Business Description